Astrana Health Reports Strong Revenue Growth in Q1 2025

Astrana Health Inc. ( (ASTH) ) has released its Q1 earnings. Here is a breakdown of the information Astrana Health Inc. presented to its investors.

Astrana Health, Inc. is a technology-powered healthcare company focused on providing high-quality, patient-centered care through its innovative platform, supporting over 12,000 providers and more than one million Americans in value-based care arrangements.

In its first quarter of 2025, Astrana Health reported significant revenue growth, reflecting its strong start to the year and ongoing momentum in building a leading patient-centered healthcare platform. Despite a challenging regulatory and economic environment, the company continues to demonstrate the scalability and sustainability of value-based care.

Key financial highlights include a 53% increase in total revenue to $620.4 million compared to the previous year, driven by a 57% rise in Care Partners revenue. However, net income decreased to $6.7 million from $14.8 million, and diluted earnings per share dropped to $0.14 from $0.31. The company’s adjusted EBITDA also saw a decline to $36.4 million from $42.2 million.

Strategically, Astrana has strengthened its leadership team with new appointments to enhance data analytics and financial scalability. The company also completed the integration of Collaborative Health Systems into its platform, achieving notable efficiencies, and received approval for its pending acquisition of Prospect Health.

Looking ahead, Astrana Health remains focused on strategic investments in automation and AI, with expectations of continued revenue and EBITDA growth. The company is poised to close its acquisition of Prospect Health this summer, further enhancing its capabilities and market position.